| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |